Liabilities / Assets
70th percentile
Higher debt load relative to assets than 70% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
70th percentile
Higher debt load relative to assets than 70% of similar nonprofits.
Liabilities / Revenue
65th percentile
Higher debt load relative to revenue than 65% of similar nonprofits.
Net Margin
19th percentile
Higher net margin than 19% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
9th percentile
Faster asset growth than 9% of similar nonprofits.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
Down$8,173,743
Down $1,145,173 (-12%) from 2011
Net Assets
Down$4,383,760
Down $981,638 (-18%) from 2011
Liabilities
Down$3,789,983
Down $163,535 (-4.1%) from 2011
Revenue
$9,848,408
No earlier filing loaded for comparison.
Expenses
Down$10,830,046
Down $8,247,429 (-43%) from 2011
Net Income
-$981,638
No earlier filing loaded for comparison.
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Mrn is dedicated to the discovery and advancement of clinical solutions for the prevention, diagnosis and treatment of mental illness and other brain disorders. Mrn is a controlled entity of lovelace respiratory research institute based in albuquerque, nm.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.